Abstract
We evaluated the new, fully automated molecular BD Max methicillin-resistant Staphylococcus aureus (MRSA) assay for detection of methicillin-resistant S. aureus in a low-prevalence (4.1%) setting. Sensitivity, specificity, and positive and negative predictive values were 93.9%, 99.2%, 83.8%, and 99.7%, respectively. The assay reported fewer unresolved results than the BD GeneOhm MRSA ACP assay.
Publication types
-
Comparative Study
-
Evaluation Study
MeSH terms
-
Automation / methods
-
Humans
-
Methicillin-Resistant Staphylococcus aureus / genetics
-
Methicillin-Resistant Staphylococcus aureus / isolation & purification*
-
Microbial Sensitivity Tests / methods
-
Molecular Diagnostic Techniques / methods*
-
Predictive Value of Tests
-
Sensitivity and Specificity
-
Staphylococcal Infections / microbiology*